Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · T. Rowe Price

T. Rowe Price Health Sciences Portfolio T. Rowe Price Health Sciences Portfolio-II (QAAHBX)

Ticker QAAHBX · Since 2002-04-30 · · Holdings as of Jun 30, 2026

Expense ratio
1.11%$111/yr per $10k
5-yr return
+3.9%annualized
1-yr return
+17.8%as of Dec 2025
Net assets
$751.7Mall share classes
Holdings
277

Bottom line

Is QAAHBX a good fund? The bottom line

QAAHBX is a share class of T. Rowe Price Health Sciences Portfolio, a managed health care sector ETF from T. Rowe Price.

It charges 1.11% — about $111 a year on every $10,000 invested, more expensive than 64% of health care sector funds we track.

It returned +17.8% over one year, +3.9% a year over five years, +8.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $752 million in net assets and 277 holdings, its largest position is Eli Lilly & Co (14.1%) and the top 10 make up 47.3% of the portfolio.

The closest lower-cost alternative we found is XLV (0.08%, 80% top-holdings overlap).

What stands out

  • Broadly diversified (277 holdings)

What to watch

  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What QAAHBX invests in

The fund seeks long-term capital appreciation.

In the Summary Prospectus, and Sections 1 and 2 of the Prospectus, the disclosure under Principal Investment Strategies is supplemented as follows: The fund is nondiversified, which means it may invest a greater percentage of its assets in a particular issuer than is permissible for a diversified fund.

From the fund's prospectus (filed Jun 30, 2026).

QAAHBX performance

Average annual total returns
1 yr5 yr10 yr
QAAHBX+17.8%+3.9%+8.7%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full QAAHBX performance history →

What QAAHBX costs

On a $10,000 investment, QAAHBX's 1.11% expense ratio costs about $111 a year. The prospectus estimates $1,352 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full QAAHBX fee table →

QAAHBX top 10 holdings

#Holding% of fund
1Eli Lilly & Co14.06%
2Johnson & Johnson6.64%
3Unitedhealth Group Inc5.88%
4Abbvie Inc5.12%
5Merck & Co. Inc.4.00%
6Gilead Sciences Inc2.79%
7Thermo Fisher Scientific Inc2.53%
8Vertex Pharmaceuticals Inc2.26%
9Bristol-myers Squibb Co2.12%
10Abbott Laboratories1.91%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 47.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to QAAHBX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%80% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%79% Compare
VanguardVHT Vanguard Health Care Index Fund0.09%79% Compare
iSharesIYH iShares U.S. Healthcare ETF0.37%77% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%58% Compare
SchwabSWHFX Schwab Health Care Fund0.8%73% Compare

More funds like QAAHBX →

QAAHBX FAQ

What is the expense ratio of QAAHBX?
QAAHBX's expense ratio is 1.11%, which works out to about $111 a year for every $10,000 invested. The prospectus estimates total costs of $1,352 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is QAAHBX a good investment?
It depends on your goals, but the data points to: broadly diversified (277 holdings); 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does QAAHBX hold?
QAAHBX's largest holdings are Eli Lilly & Co (14.1%), Johnson & Johnson (6.6%), Unitedhealth Group Inc (5.9%), Abbvie Inc (5.1%), Merck & Co. Inc. (4.0%). It holds 277 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is QAAHBX's 5-year return?
QAAHBX returned +3.9% a year over the five years ending Dec 31, 2025, and +8.7% a year over ten years. Past performance does not guarantee future results.
What is a cheaper alternative to QAAHBX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 80% with QAAHBX and charges 0.08%.
Who manages QAAHBX?
QAAHBX is offered by T. Rowe Price through T. Rowe Price Equity Series, Inc..